Feeds:
Posts
Comments

Archive for the ‘DellaCamera Capital Management’ Category

CuraGen Corporation (NASDAQ:CRGN) Q1 update; Greenbackd exits

Posted in Activist Investors, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Net Cash Stocks, Stocks, tagged , , , on May 18, 2009 | Leave a Comment »

CuraGen Corporation (NASDAQ:CRGN) has filed its 10Q for the period ended March 31, 2009. CRGN’s stock has risen strongly over the last few months, and is now trading at $1.02, giving it a market capitalization slightly higher than our estimate of its liquidation value. Accordingly, we’re going to take this opportunity to exit. The stock [...]

Read Full Post »

List of activist investments for March

Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Stocks, tagged , , , , on April 13, 2009 | Leave a Comment »

The Official Activist Investing Blog has published its list of activist investments for March (links are to the relevant post archive for our open positions): Ticker Company Investor ACTL Actel Corp Ramius Capital AGYS Agilysys Inc Ramius Capital AMLN Amylin Pharmaceuticals Eastbourne Capital ASPM Aspect Medical Systems First Manhattan Co ASPM Aspect Medical Systems Coghill [...]

Read Full Post »

CuraGen Corporation (NASDAQ:CRGN) 10K update

Posted in CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Net Cash Stocks, Stocks, tagged , , , , on March 13, 2009 | Leave a Comment »

CuraGen Corporation (NASDAQ:CRGN) has filed its 10K for the fiscal year ended December 31, 2008. We’ve been following CRGN since January 20, 2009 (see our post archive here) because it is a net cash stock with an investor, DellaCamera Capital Management, pushing the company to seek “alternative deployment of [its] capital.” DellaCamera Capital Management has [...]

Read Full Post »

DellaCamera Capital Management ups stake in CRGN

Posted in Activist Investors, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Net Cash Stocks, Stocks, tagged , , , on March 6, 2009 | Leave a Comment »

DellaCamera Capital Management has increased its stake in CuraGen Corporation (NASDAQ:CRGN) from 5.6% to 6.5% and nominated two candidates to the board. We’ve been following CRGN since January 20, 2009 (see our post archive here) because it is a net cash stock with an investor, DellaCamera Capital Management, pushing the company to seek “alternative deployment [...]

Read Full Post »

CRGN to evaluate strategic options

Posted in Activist Investors, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Net Cash Stocks, Stocks, tagged , , , on February 24, 2009 | Leave a Comment »

CuraGen Corporation (NASDAQ:CRGN) has announced that it is considering strategic alternatives to enhance shareholder value including selling or licensing CR011, acquiring additional assets or business lines, or selling the company. We started following CRGN on January 20 this year because it is a net cash stock with an investor, DellaCamera Capital Management, disclosing a 5.6% [...]

Read Full Post »

List of activist investments for January

Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Dolphin Limited Partnership, GAMCO, Icagen Inc (NASDAQ:ICGN), Mill Road Capital, Multimedia Games Inc (NASDAQ:MGAM), Nery Capital Partners, Stocks, tagged , , , , , , , , on February 10, 2009 | Leave a Comment »

The Official Activist Investing Blog has published its list of activist investments for January (the investments with links are to our latest update at the time of this post): Ticker Company Activist Investor ABVA Alliance Bankshares Corp John Edgemond AMLN Amylin Pharmaceuticals Carl Icahn; Eastbourne Capital AVGN Avigen Inc. Biotechnology Value Fund BIOD Biodel Inc [...]

Read Full Post »

CuraGen Corporation (NASDAQ:CRGN)

Posted in Activist Investors, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Net Cash Stocks, Stocks, tagged , , , on January 20, 2009 | 1 Comment »

CuraGen Corporation (NASDAQ:CRGN) is a net cash stock with an investor, DellaCamera Capital Management, disclosing a 5.6% holding in a 13D filed on January 15. At its $0.67 closing price Friday, CRGN’s market capitalization is $38.5M. We estimate CRGN’s net cash value to be 60% higher at $62M or $1.07 per share. The company is [...]

Read Full Post »